Artificial Pancreas Pipeline Market Report Overview
The artificial pancreas helps people with diabetes, primarily type 1, to automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
The artificial pancreas pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The US
· Europe · China · Japan · South Korea |
| Key Regulatory Paths | · PMA
· CE · 510(k) · NMPA · Shonin |
| Leading Companies | · Admetsys Corp
· Advanced Biosensors-Ohio LLC · AiTA Bio Inc · Beta-O2 Technologies Ltd · Bigfoot Biomedical Inc |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Artificial Pancreas Pipeline Market Segmentation by Territories
A few of the key territories with the artificial pancreas pipeline market are the US, Europe, China, Japan, and South Korea. As of September 2024, the US accounted for the highest number of pipeline products.
Artificial Pancreas Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Artificial Pancreas Pipeline Market
Artificial Pancreas Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the artificial pancreas pipeline products market are PMA, CE, 510(k), NMPA, and Shonin. As of September 2024, PMA was the most followed pathway for pipeline products in the artificial pancreas market.
Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Artificial Pancreas Pipeline Market
Artificial Pancreas Pipeline Market – Competitive Landscape
A few of the key companies associated with the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, AiTA Bio Inc, Beta-O2 Technologies Ltd, and Bigfoot Biomedical Inc., among others.
Beta-O2 Technologies Ltd: Headquartered in Rosh HaAyin, Israel, it is a biomedical company that develops proprietary implantable bio-artificial pancreas for the treatment of type 1 diabetes. The company’s bio-artificial pancreas is an implantable device that allows for immune isolation of the implanted cells, eliminating the need for frequent insulin injections, glucose measurements, and immunosuppressive therapy. Beta-O2 preclinically tests the bio-artificial adrenal as a treatment for stress disorders.
Bigfoot Biomedical Inc.: It is a medical device company that develops technologies to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. It leverages data, connectivity, automation, and machine learning to automatically and continuously optimize insulin delivery for people with insulin-requiring diabetes and maximize the leverage of healthcare providers. Bigfoot Biomedical provides automated infusion pumps and connected insulin pen options for consumers to meet the needs of a diverse population with insulin-requiring diabetes.
Artificial Pancreas Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Artificial Pancreas Pipeline Market
Segments Covered in the Report
Artificial Pancreas Pipeline Market Territories Outlook (2024)
- The US
- Europe
- China
- Japan
- South Korea
Artificial Pancreas Pipeline Market Regulatory Paths Outlook (2024)
- PMA
- CE
- 510(k)
- NMPA
- Shonin
Scope of Report
This report provides:
- Extensive coverage of the artificial pancreas under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- Reviews of the major players involved in the development of artificial pancreas and lists all their pipeline projects.
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of artificial pancreas under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Key Stakeholders
Table of Contents
Tables
Artificial Pancreas – Pipeline Products by Stage of Development 13
Artificial Pancreas – Pipeline Products by Territory 14
Artificial Pancreas – Pipeline Products by Regulatory Path 15
Artificial Pancreas – Pipeline Products by Estimated Approval Date 16
Artificial Pancreas – Ongoing Clinical Trials 17
Artificial Pancreas Companies – Pipeline Products by Stage of Development 18
Artificial Pancreas – Pipeline Products by Stage of Development 21
Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 23
Smart Pancreas – Product Status 23
Smart Pancreas – Product Description 24
Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Artificial Pancreas – Product Status 25
Artificial Pancreas – Product Description 25
AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Next-Generation Artificial Pancreas – Product Status 26
Next-Generation Artificial Pancreas – Product Description 26
Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Gen 2 GlucoSTAT – Product Status 27
Gen 2 GlucoSTAT – Product Description 27
Gen 4 iLet System – Product Status 28
Gen 4 iLet System – Product Description 28
Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
ßAir Bio-artificial Pancreas – Product Status 29
ßAir Bio-artificial Pancreas – Product Description 29
Beta-O2 Technologies Ltd – Ongoing Clinical Trials Overview 30
ßAir Bio-artificial Pancreas – An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-air in Patients with Type 1 Diabetes Mellitus 31
Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Bigfoot Autonomy – Product Status 32
Bigfoot Autonomy – Product Description 32
BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Artificial Pancreas – Product Status 33
Artificial Pancreas – Product Description 33
Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
IMITA Device – Product Status 34
IMITA Device – Product Description 34
Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Bioartificial Pancreas – Product Status 35
Bioartificial Pancreas – Product Description 35
Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 36
Bihormonal Bionic Pancreas – Product Status 36
Bihormonal Bionic Pancreas – Product Description 36
Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Bioartificial Pancreas System – Product Status 37
Bioartificial Pancreas System – Product Description 37
Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
Artificial Pancreas – Product Status 38
Artificial Pancreas – Product Description 38
De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 39
InSmart Artificial Pancreas – Product Status 39
InSmart Artificial Pancreas – Product Description 39
Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 40
Next Generation Artificial Pancreas – Product Status 40
Next Generation Artificial Pancreas – Product Description 40
Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 41
MAILPAN – Product Status 41
MAILPAN – Product Description 41
Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 42
Automated Insulin Delivery System – Product Status 42
Automated Insulin Delivery System – Product Description 42
DBLG1 – Pediatric Version – Product Status 43
DBLG1 – Pediatric Version – Product Description 43
EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
EOPatchX – Product Status 44
EOPatchX – Product Description 44
Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 45
BAPIOS System – Product Status 45
BAPIOS System – Product Description 45
Haimai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Biological Pancreas – Product Status 46
Biological Pancreas – Product Description 46
Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 47
Pregnancy-Specific Artificial Pancreas – Product Status 47
Pregnancy-Specific Artificial Pancreas – Product Description 47
Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Bioengineered Pancreas – Product Status 48
Bioengineered Pancreas – Product Description 48
Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 49
BioVascular Pancreas – Product Status 49
BioVascular Pancreas – Product Description 49
Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Fusion System – Product Status 50
Fusion System – Product Description 50
Ideal Medical Technologies Inc – Ongoing Clinical Trials Overview 51
Fusion System – Demonstration of an Artificial Intelligence Based Closed Loop Glucose Control System as a Therapeutic Modality in Type 1 and Type 2 Diabetic Patients 52
Fusion System – Prospective Randomized Controlled Trial For Use of the FUSION Artificial Pancreas System as a Therapy for COVID-19 52
Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 53
Bio-inspired Artificial Pancreas – Product Status 53
Bio-inspired Artificial Pancreas – Product Description 53
Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 54
Artificial Pancreas System – Product Status 54
Artificial Pancreas System – Product Description 54
Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 55
Closed-Loop Glucagon Delivery System – Product Status 55
Closed-Loop Glucagon Delivery System – Product Description 55
Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
Artificial Pancreas System – Product Status 56
Artificial Pancreas System – Product Description 56
Semi-Closed-Loop Blood Glucose Management Device – Product Status 57
Semi-Closed-Loop Blood Glucose Management Device – Product Description 57
Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 58
BioArtificial Pancreas – Product Status 58
BioArtificial Pancreas – Product Description 58
Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 59
Artificial Pancreas – Product Status 59
Artificial Pancreas – Product Description 59
McGill University Pipeline Products & Ongoing Clinical Trials Overview 60
Artificial Pancreas – Type 1 Diabetes – Product Status 60
Artificial Pancreas – Type 1 Diabetes – Product Description 60
Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Implantable Artificial Pancreas Device – Product Status 61
Implantable Artificial Pancreas Device – Product Description 61
Third-Generation Artificial Pancreas System – Product Status 62
Third-Generation Artificial Pancreas System – Product Description 62
Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Minimed 890G – Product Status 63
Minimed 890G – Product Description 63
MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 64
PanCares – Artificial Pancreas – Product Status 64
PanCares – Artificial Pancreas – Product Description 64
PanCares – Children And Adolescents – Product Status 65
PanCares – Children And Adolescents – Product Description 65
Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Miro Pancreas – Product Status 66
Miro Pancreas – Product Description 66
Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
MODD2 – Product Status 67
MODD2 – Product Description 67
Novoculi Pipeline Products & Ongoing Clinical Trials Overview 68
Closed-Loop System – Product Status 68
Closed-Loop System – Product Description 68
Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 69
SynerG – Product Status 69
SynerG – Product Description 69
Pacific Diabetes Technologies Inc – Ongoing Clinical Trials Overview 70
SynerG – A 48hr Study to Test Feasibility of the Pacific Diabetes Technologies Continuous Glucose Monitor Infusion Set (CGMIS) Sensing Interstitial Glucose Continuously in the Immediate Vicinity of SQ Insulin Delivery in Adults With T1 Diabetes 71
SynerG – A Seven Day Study of the SynerG Insulin-Delivery and Glucose Sensor System in Persons with Type 1 Diabetes 71
SynerG – Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes 71
Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 72
Genesis Artificial Pancreas – Product Status 72
Genesis Artificial Pancreas – Product Description 72
PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Bio-Artificial Pancreas – Product Status 73
Bio-Artificial Pancreas – Product Description 73
Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 74
ClosedLoop 4Meal – Product Status 74
ClosedLoop 4Meal – Product Description 74
Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 75
Closed-Loop Artificial Pancreas System – Product Status 75
Closed-Loop Artificial Pancreas System – Product Description 75
Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Status 76
Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Description 76
SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 77
Pod Automated Insulin Delivery Device – Product Status 77
Pod Automated Insulin Delivery Device – Product Description 77
Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
Bioartificial Pancreas – Type I Diabetes – Product Status 78
Bioartificial Pancreas – Type I Diabetes – Product Description 78
Stanford University Pipeline Products & Ongoing Clinical Trials Overview 79
Artificial Pancreas Device – Product Status 79
Artificial Pancreas Device – Product Description 79
TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Artificial Pancreas – Product Status 80
Artificial Pancreas – Product Description 80
Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 81
Stabilized and Ultra-Rapid Insulin Pump – Product Status 81
Stabilized and Ultra-Rapid Insulin Pump – Product Description 81
StampPump – Product Status 82
StampPump – Product Description 82
TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 83
inControl – Product Status 83
inControl – Product Description 83
TypeZero Technologies LLC – Ongoing Clinical Trials Overview 84
inControl – Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump 85
U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 86
Microneedle Artificial Pancreas – Product Status 86
Microneedle Artificial Pancreas – Product Description 86
Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 87
Predictive Rule-Based Algorithm – Product Status 87
Predictive Rule-Based Algorithm – Product Description 87
University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 88
Implantable Bioartificial Pancreas – Product Status 88
Implantable Bioartificial Pancreas – Product Description 88
University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 89
Closed-Loop Artificial Pancreas – Product Status 89
Closed-Loop Artificial Pancreas – Product Description 89
Pediatric Artificial Pancreas – Product Status 90
Pediatric Artificial Pancreas – Product Description 90
University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 91
Artificial Pancreas – Type 2 Diabetes – Product Status 91
Artificial Pancreas – Type 2 Diabetes – Product Description 91
Florence D2A System – Product Status 92
Florence D2A System – Product Description 92
FlorenceM – Product Status 92
FlorenceM – Product Description 93
University of Florida Pipeline Products & Ongoing Clinical Trials Overview 94
Bioartificial Pancreas – Type 1 Diabetes – Product Status 94
Bioartificial Pancreas – Type 1 Diabetes – Product Description 94
University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 95
Implantable Microvalve Device – Product Status 95
Implantable Microvalve Device – Product Description 95
University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 96
Closed Glucose-Sensing Insulin-Delivery System – Product Status 96
Closed Glucose-Sensing Insulin-Delivery System – Product Description 96
University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 97
Bionic Artificial Pancreas – Product Status 97
Bionic Artificial Pancreas – Product Description 97
University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 98
Neural Net Artificial Pancreas – Product Status 98
Neural Net Artificial Pancreas – Product Description 98
ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 99
Kaleido Hybrid Closed Loop System – Product Status 99
Kaleido Hybrid Closed Loop System – Product Description 99
WaveForm Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 100
Closed Loop Insulin Delivery Solution – Product Status 100
Closed Loop Insulin Delivery Solution – Product Description 100
Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 101
Bi-Hormonal Artificial Pancreas – Product Status 101
Bi-Hormonal Artificial Pancreas – Product Description 101
Yale University Pipeline Products & Ongoing Clinical Trials Overview 102
Automated Insulin Delivery System – Product Status 102
Automated Insulin Delivery System – Product Description 102
Glossary 114
Graphs
Artificial Pancreas – Pipeline Products by Stage of Development 13
Artificial Pancreas – Pipeline Products by Territory 14
Artificial Pancreas – Pipeline Products by Regulatory Path 15
Artificial Pancreas – Pipeline Products by Estimated Approval Date 16
Artificial Pancreas – Ongoing Clinical Trials 17









